In addition to those functions that have been extensively addressed in this
special issue, such as nociception, motor activity, neuroendocrine regulat
ion, immune function and others, the endogenous cannabinoid system seems to
play also a role in neural development. This view is based on a three-fold
evidence. A first evidence emerges from neurotoxicological studies that sh
owed that synthetic and plant-derived cannabinoids, when administered to pr
egnant rats, produced a variety of changes in the maturation of several neu
rotransmitters and their associated-behaviors in their pups, changes that w
ere evident at different stages of brain development. A second evidence com
es from studies that demonstrated the early appearance of elements of the e
ndogenous cannabinoid system (receptors and ligands) during the brain devel
opment. The atypical location of these elements during fetal and early post
natal periods favours the notion that this system may play a role in specif
ic molecular events related to neural development. Finally, a third evidenc
e derives from studies using cultures of fetal glial or neuronal cells. Can
nabinoid receptors are present in some of these cultured cells and their ac
tivation produced a set of cellular effects consistent with a role of this
system in the process of neural development. All this likely supports that
endocannabinoids, early synthesized in nervous cells, play a role in events
related to development, by acting through the activation of second messeng
er-coupled cannabinoid receptors.